These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 25637565)

  • 1. Chemoradiation therapy using cyclopamine-loaded liquid-lipid nanoparticles and lutetium-177-labeled core-crosslinked polymeric micelles.
    You J; Zhao J; Wen X; Wu C; Huang Q; Guan F; Wu R; Liang D; Li C
    J Control Release; 2015 Mar; 202():40-8. PubMed ID: 25637565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclopamine-loaded core-cross-linked polymeric micelles enhance radiation response in pancreatic cancer and pancreatic stellate cells.
    Zhao J; Wu C; Abbruzzese J; Hwang RF; Li C
    Mol Pharm; 2015 Jun; 12(6):2093-100. PubMed ID: 25936695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Micellar delivery of cyclopamine and gefitinib for treating pancreatic cancer.
    Chitkara D; Singh S; Kumar V; Danquah M; Behrman SW; Kumar N; Mahato RI
    Mol Pharm; 2012 Aug; 9(8):2350-7. PubMed ID: 22780906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A radio-theranostic nanoparticle with high specific drug loading for cancer therapy and imaging.
    Satterlee AB; Yuan H; Huang L
    J Control Release; 2015 Nov; 217():170-82. PubMed ID: 26341695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biodistribution and therapeutic efficacy of (125/131)I-, (186)Re-, (88/90)Y-, or (177)Lu-labeled monoclonal antibody MN-14 to carcinoembryonic antigen in mice with small peritoneal metastases of colorectal origin.
    Koppe MJ; Bleichrodt RP; Soede AC; Verhofstad AA; Goldenberg DM; Oyen WJ; Boerman OC
    J Nucl Med; 2004 Jul; 45(7):1224-32. PubMed ID: 15235070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclopamine disrupts tumor extracellular matrix and improves the distribution and efficacy of nanotherapeutics in pancreatic cancer.
    Zhang B; Jiang T; Shen S; She X; Tuo Y; Hu Y; Pang Z; Jiang X
    Biomaterials; 2016 Oct; 103():12-21. PubMed ID: 27376555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted systemic radiotherapy with scVEGF/177Lu leads to sustained disruption of the tumor vasculature and intratumoral apoptosis.
    Blankenberg FG; Levashova Z; Goris MG; Hamby CV; Backer MV; Backer JM
    J Nucl Med; 2011 Oct; 52(10):1630-7. PubMed ID: 21890879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted antisense radiotherapy and dose fractionation using a (177)Lu-labeled anti-bcl-2 peptide nucleic acid-peptide conjugate.
    Liu D; Balkin ER; Jia F; Ruthengael VC; Smith CJ; Lewis MR
    Nucl Med Biol; 2015 Sep; 42(9):704-10. PubMed ID: 26081917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual-Receptor-Targeted Radioimmunotherapy of Human Breast Cancer Xenografts in Athymic Mice Coexpressing HER2 and EGFR Using 177Lu- or 111In-Labeled Bispecific Radioimmunoconjugates.
    Razumienko EJ; Chen JC; Cai Z; Chan C; Reilly RM
    J Nucl Med; 2016 Mar; 57(3):444-52. PubMed ID: 26429962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of Gold Nanoparticle-Conjugated Tumor Necrosis Factor-α and Radiation Therapy Results in a Synergistic Antitumor Response in Murine Carcinoma Models.
    Koonce NA; Quick CM; Hardee ME; Jamshidi-Parsian A; Dent JA; Paciotti GF; Nedosekin D; Dings RP; Griffin RJ
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):588-96. PubMed ID: 26461001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [177Lu]pertuzumab: experimental therapy of HER-2-expressing xenografts.
    Persson M; Gedda L; Lundqvist H; Tolmachev V; Nordgren H; Malmström PU; Carlsson J
    Cancer Res; 2007 Jan; 67(1):326-31. PubMed ID: 17210714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sonic Hedgehog inhibition as a strategy to augment radiosensitivity of hepatocellular carcinoma.
    Tsai CL; Hsu FM; Tzen KY; Liu WL; Cheng AL; Cheng JC
    J Gastroenterol Hepatol; 2015 Aug; 30(8):1317-24. PubMed ID: 25682950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stromal Modulation Reverses Primary Resistance to Immune Checkpoint Blockade in Pancreatic Cancer.
    Zhao J; Xiao Z; Li T; Chen H; Yuan Y; Wang YA; Hsiao CH; Chow DS; Overwijk WW; Li C
    ACS Nano; 2018 Oct; 12(10):9881-9893. PubMed ID: 30231203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyaluronic acid functional amphipathic and redox-responsive polymer particles for the co-delivery of doxorubicin and cyclopamine to eradicate breast cancer cells and cancer stem cells.
    Hu K; Zhou H; Liu Y; Liu Z; Liu J; Tang J; Li J; Zhang J; Sheng W; Zhao Y; Wu Y; Chen C
    Nanoscale; 2015 May; 7(18):8607-18. PubMed ID: 25898852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential use of lapatinib-loaded human serum albumin nanoparticles in the treatment of triple-negative breast cancer.
    Wan X; Zheng X; Pang X; Zhang Z; Jing T; Xu W; Zhang Q
    Int J Pharm; 2015 Apr; 484(1-2):16-28. PubMed ID: 25700543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 177Lu-labeled antibodies for EGFR-targeted SPECT/CT imaging and radioimmunotherapy in a preclinical head and neck carcinoma model.
    Liu Z; Ma T; Liu H; Jin Z; Sun X; Zhao H; Shi J; Jia B; Li F; Wang F
    Mol Pharm; 2014 Mar; 11(3):800-7. PubMed ID: 24472064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioimmunotherapy of a human lung cancer xenograft with monoclonal antibody RS7: evaluation of (177)Lu and comparison of its efficacy with that of (90)Y and residualizing (131)I.
    Stein R; Govindan SV; Chen S; Reed L; Richel H; Griffiths GL; Hansen HJ; Goldenberg DM
    J Nucl Med; 2001 Jun; 42(6):967-74. PubMed ID: 11390564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the therapeutic efficacy of 188Rhenium-liposomes and liposomal doxorubicin in a 4T1 murine orthotopic breast cancer model.
    Liu CM; Lee WC; Yu CY; Lan KL; Chang CH; Ting G; Lee TW
    Oncol Rep; 2012 Mar; 27(3):678-84. PubMed ID: 22109644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Efficacy of Radioimmunotherapy with 90Y-Labeled Fully Human Anti-Transferrin Receptor Monoclonal Antibody in Pancreatic Cancer Mouse Models.
    Sugyo A; Tsuji AB; Sudo H; Okada M; Koizumi M; Satoh H; Kurosawa G; Kurosawa Y; Saga T
    PLoS One; 2015; 10(4):e0123761. PubMed ID: 25893775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel nanosystem to enhance the antitumor activity of lapatinib in breast cancer treatment: Therapeutic efficacy evaluation.
    Huo ZJ; Wang SJ; Wang ZQ; Zuo WS; Liu P; Pang B; Liu K
    Cancer Sci; 2015 Oct; 106(10):1429-37. PubMed ID: 26177628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.